Results 81 to 90 of about 24,826 (263)

LIPOPROTEIN (A) AND FIBRINOLYTIC SYSTEM IN LIVER-CIRRHOSIS

, 1995
Several observations have suggested that lipoprotein (a) (Lp(a)) is a risk factor for coronary artery disease because of potential interference with fibrinolysis secondary to its activation of plasminogen. However, there are few data on the possible role
CIMMINIELLO C, TOSCHI V, GEROSA MC, ARPAIA G, VIGORELLI P, BALSANO F, FERRO D, CORDOVA C., UBERTI T, MOSCA A, SONCINI M, BONFARDECI G, MOTTA A, SALVI A, IULIANO, Luigi, PRATICO D, VIOLI F, QUINTARELLI C   +17 more
core   +1 more source

Glycemic Control, Animal Protein Intake, and the Risk of Diabetic Retinopathy Progression Among Patients With Type 2 Diabetes

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Effective glycemic control and food consumption play crucial roles in modulating diabetic retinopathy (DR) progression. This observational longitudinal study explored the hemoglobin A1c (HbA1c) and dietary patterns and their associations with the risk and progression of DR among 369 individuals with type 2 diabetes.
Yu‐Ju Wu, Chih‐Cheng Hsu, Chih‐Yiu Tsai, Shang‐Jyh Hwang, Kun‐Der Lin, Pi‐Chen Lin, Ya‐Fang Huang, Chiao‐I Chang, Meng‐Chuan Huang   +8 more
wiley   +1 more source

Impact of Cardiometabolic Risk Factors and Steatotic Liver Disease on Liver‐Related Outcomes in Patients With Chronic Hepatitis C After Curative Antiviral Therapy

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Patients with chronic hepatitis C (CHC) frequently present with steatotic liver disease (SLD) and cardiometabolic risk factors (CMRFs). This study aimed to evaluate the impact of SLD and CMRFs on liver‐related outcomes (LROs) in CHC patients after HCV eradication.
Chung‐Feng Huang, Yi‐Hung Lin, Pei‐Chien Tsai, Ming‐Lun Yeh, Chih‐Wen Wang, Tyng‐Yuan Jang, Po‐Cheng Liang, Yu‐Ju Wei, Nai‐Jen Hou, Ming‐Yen Hsieh, Chao‐Kuan Huang, Tzu‐Chun Lin, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chuang, Ming‐Lung Yu   +15 more
wiley   +1 more source

Correlation of lipoprotein (a) [Lp(a)] with other lipoprotein classes

, 2007
OBJECTIVE: Lipoprotein (a) Lp(a) can be defined as a lipoprotein particle having as a protein moiety apolipoprotein B-100 disulfide-linked to apolipoprotein (a), the distinctive glycoprotein of Lp(a) that is holologus to plasminogen.
Charalampopoulou, Athina, Χαραλαμποπούλου, Αθηνά   +1 more
core   +1 more source

Metabolic Dysfunction‐Associated Steatotic Liver Disease and Obesity: Pathogenesis, Diagnostics, Risk Stratification, and Therapeutic Approach

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) has emerged as the most prevalent chronic liver disease worldwide, closely linked to the global rising incidence of obesity and metabolic syndrome. This review synthesizes current evidence on the pathogenesis, gut–liver axis, and multidisciplinary management of MASLD within the ...
Beom Kyung Kim
wiley   +1 more source

Lipoprotein (a) plasma levels and lipoprotein status: comparison among adult healthy subjects, hospitalized patients and free living over 80 years old

, 1997
BACKGROUND: Lipoprotein(a) (Lp(a)) assessment seems to be a useful contribution to the study of lipoprotein profile in patients at risk for arteriosclerosis-related diseases.
T. Imbastaro, A. Riario Sforza, ZULIANI, Giovanni, C. Romano, G. bader, A. Mezzetti, C. Cappelli, G. Riario Sforza   +7 more
core  

Electroelution of lipoprotein(a) [Lp(a)] from native polyacrylamide gels: A new, simple method to purify Lp(a)

, 2006
Lipoprotein(a), Lp(a), is an atherogenic lipoprotein consisting of an LDL like core particle and a covalently linked glycoprotein of variable size. Lp(a). isolated front serum always contains LDL and HDL, as contaminants since Lp(a) floats in the density

core   +1 more source

Preclinical Evaluation of Berry Extracts as a Nutritional Intervention to Alleviate Myocardial Ischemia–Reperfusion Injury and Atherosclerosis Development

Phytotherapy Research, EarlyView.
Schematic representation of the experimental design and the proposed mechanisms underlying the cardioprotective and anti‐atherosclerotic effects of Greek‐derived berry extracts. C57BL/6 mice with WD–induced MS and ApoE−/− mice with atherosclerosis received chronic supplementation with WMex or BBex.
Lydia Symeonidi, Panagiota‐Efstathia Nikolaou, Panagiotis Stathopoulos, Andriana Christodoulou, Alexandra Svouraki, Panagiotis Efentakis, Christina Chania, Angeliki Choustoulaki, Maria Xenaki, Anna Agapaki, Maria Tsoumani, Nikolaos Kostomitsopoulos, Ioulia Tseti, Gemma Vilahur, Alexios‐Leandros Skaltsounis, Ioanna Andreadou   +15 more
wiley   +1 more source

Therapeutic modulation of lipoprotein-associated phospholipase A2 (Lp-PLA2)

, 2011
Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a calcium-independent phospholipase A2 that circulates in plasma in association with lipoprotein particles, whereas in atherosclerotic plaques it is co-localized with macrophages. Lp-PLA2 generates two
Rizzo, M., Goudevenos, I. A., Tselepis, A. F.   +2 more
core   +1 more source

Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification. [PDF]

BMC Med Genet, 2020
Pechlivanis S, Mahabadi AA, Hoffmann P, Nöthen MM, Broecker-Preuss M, Erbel R, Moebus S, Stang A, Jöckel KH.   +8 more
europepmc   +1 more source